SARON Trial | Lung Cancer Nursing UK Skip to main content

SARON Trial

The NLCFN has been contacted by the trial coordinator for the SARON trial based at CRUK &; UCL Cancer Trials Centre (UCL CTC) in London. They are looking at opportunities to promote this national lung trial. The trial is funded by CRUK, sponsored by UCL and coordinated at UCL CTC. The Chief Investigator of this trial is Dr David Lindau. Currently, there are 12 centres throughout the UK with an aim of having about 30 centres in total. Information about the trial  can be viewed at: http://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-stereotactic-ablative-radiotherapy-for-non-small-cell-lung-cancer-saron The trial patient population  is stage IV non small cell lung cancer, with metastatic disease (not more than 3 areas). SARON is a randomised trial where patients will have either chemotherapy only (standard) or chemotherapy plus radiotherapy (it could be conventional radiotherapy, or stereotactic ablative radiotherapy (SABR) and/or stereotactic radiosurgery (SRS). 

Tags

Join Lung Cancer Nursing UK

Be a member of a dynamic and cohesive forum of lung cancer nurse specialists (LCNS) working throughout the UK. Membership costs just £30 per year and is open to any specialist nurse who spends more than 50% of their working week or clinical activities in caring for patients with lung cancer.

Join Now

LCNUK Webinars

Our series of webinars will be continuing throughout 2023.

We hope you can join us on online.

Register for Upcoming Webinars